Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.

Bengt Lindahl, Jan Persson, Jonas Ranstam, Roger Willén

Research output: Contribution to journalArticlepeer-review

8 Citations (SciVal)


Uterine clear cell carcinoma (UCC) and uterine papillary serous carcinoma (UPSC) are rare entities that differ in clinical behavior from endometrial adenocarcinoma. Compared with endometrioid adenocarcinoma, they more often metastasize early and more commonly in the upper abdomen including the omentum. Treatment programs of UCC and UPSC at different stages vary and range from no adjuvant therapy in stage Ia to a wide variety of chemotherapies and radiotherapies in more advanced stages. This study presents the outcome of 109 patients with UCC or UPSC treated according to essentially the same treatment program from May 1993 to December 2004. Most patients were treated with a simple hysterectomy with no further adjuvant treatment. In stage Ia, 2/46 patients died of their disease and amongst all the stages, 30/109 patients died of their disease. These survival outcomes are comparable to or better than those presented previously.
Original languageEnglish
Pages (from-to)3727-3730
JournalAnticancer research
Issue number9
Publication statusPublished - 2010

Subject classification (UKÄ)

  • Cancer and Oncology


Dive into the research topics of 'Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.'. Together they form a unique fingerprint.

Cite this